Thursday, January 26, 2017

Hooray for CVS - Taking a Bit Out of the Greedy Bastards at EpiPen

Hey Drug Companies, Getting the Message Yet?

One of the many scandals of America is that this nation allows private companies to have monopolies on life saving phramaceuticals.  Instead of having public financing of drug research so that the benefits are available to everyone, this country gives private for profit companies the right to be sole manufacturers of drugs necessary for people to live.  And what does a private for profit company do with this power, well they maximize profit.

But CVS has stepped into one area and lo and behold .  . .

Image result for images of greed
The motto of the American pharmaceutical industry

"Last year the makers of EpiPen decided to raise their prices to astronomical levels, and why not.  They had little competiton.  But it turns out they did have some, and now CVS is teaming up with that competition to kick some butt.

The nation’s biggest drug store chain said the generic version of Adrenaclick – a tiny EpiPen competitor – costs $109.99 per two-pack. That compares to just over $600 a pack for the EpiPen and $300 for the generic EpiPen that local drug giant Mylan launched last month.
“We recognized the urgent need for a less-expensive epinephrine auto-injector, and are proud to offer a low-cost option,” CVS said in a statement. The Rhode Island-based company has some 9,600 stores nationwide.
The generic Adrenaclick, sold by Impax Laboratories in California, contains the same active ingredient to counteract life-threatening allergic reactions as the EpiPen, but uses a slightly different delivery system. The brand-name version of Adrenaclick is no longer manufactured."
Well done CVS, well done!

No comments:

Post a Comment